206 related articles for article (PubMed ID: 24980573)
1. Identification of a melanoma susceptibility locus and somatic mutation in TET2.
Song F; Amos CI; Lee JE; Lian CG; Fang S; Liu H; MacGregor S; Iles MM; Law MH; Lindeman NI; Montgomery GW; Duffy DL; Cust AE; Jenkins MA; Whiteman DC; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Brown KM; Martin NG; Mann GJ; Bishop DT; Bishop JA; ; Kraft P; Qureshi AA; Kanetsky PA; Hayward NK; Hunter DJ; Wei Q; Han J
Carcinogenesis; 2014 Sep; 35(9):2097-101. PubMed ID: 24980573
[TBL] [Abstract][Full Text] [Related]
2. Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia.
Setiawan VW; Schumacher F; Prescott J; Haessler J; Malinowski J; Wentzensen N; Yang H; Chanock S; Brinton L; Hartge P; Lissowska J; Park SL; Cheng I; Bush WS; Crawford DC; Ursin G; Horn-Ross P; Bernstein L; Lu L; Risch H; Yu H; Sakoda LC; Doherty J; Chen C; Jackson R; Yasmeen S; Cote M; Kocarnik JM; Peters U; Kraft P; De Vivo I; Haiman CA; Kooperberg C; Le Marchand L
Carcinogenesis; 2014 Sep; 35(9):2068-73. PubMed ID: 24832084
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies three new melanoma susceptibility loci.
Barrett JH; Iles MM; Harland M; Taylor JC; Aitken JF; Andresen PA; Akslen LA; Armstrong BK; Avril MF; Azizi E; Bakker B; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Corda E; Cust AE; Dębniak T; Duffy D; Dunning AM; Easton DF; Friedman E; Galan P; Ghiorzo P; Giles GG; Hansson J; Hocevar M; Höiom V; Hopper JL; Ingvar C; Janssen B; Jenkins MA; Jönsson G; Kefford RF; Landi G; Landi MT; Lang J; Lubiński J; Mackie R; Malvehy J; Martin NG; Molven A; Montgomery GW; van Nieuwpoort FA; Novakovic S; Olsson H; Pastorino L; Puig S; Puig-Butille JA; Randerson-Moor J; Snowden H; Tuominen R; Van Belle P; van der Stoep N; Whiteman DC; Zelenika D; Han J; Fang S; Lee JE; Wei Q; Lathrop GM; Gillanders EM; Brown KM; Goldstein AM; Kanetsky PA; Mann GJ; Macgregor S; Elder DE; Amos CI; Hayward NK; Gruis NA; Demenais F; Bishop JA; Bishop DT;
Nat Genet; 2011 Oct; 43(11):1108-13. PubMed ID: 21983787
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
Law MH; Bishop DT; Lee JE; Brossard M; Martin NG; Moses EK; Song F; Barrett JH; Kumar R; Easton DF; Pharoah PDP; Swerdlow AJ; Kypreou KP; Taylor JC; Harland M; Randerson-Moor J; Akslen LA; Andresen PA; Avril MF; Azizi E; Scarrà GB; Brown KM; Dębniak T; Duffy DL; Elder DE; Fang S; Friedman E; Galan P; Ghiorzo P; Gillanders EM; Goldstein AM; Gruis NA; Hansson J; Helsing P; Hočevar M; Höiom V; Ingvar C; Kanetsky PA; Chen WV; ; ; ; ; ; ; Landi MT; Lang J; Lathrop GM; Lubiński J; Mackie RM; Mann GJ; Molven A; Montgomery GW; Novaković S; Olsson H; Puig S; Puig-Butille JA; Qureshi AA; Radford-Smith GL; van der Stoep N; van Doorn R; Whiteman DC; Craig JE; Schadendorf D; Simms LA; Burdon KP; Nyholt DR; Pooley KA; Orr N; Stratigos AJ; Cust AE; Ward SV; Hayward NK; Han J; Schulze HJ; Dunning AM; Bishop JAN; Demenais F; Amos CI; MacGregor S; Iles MM
Nat Genet; 2015 Sep; 47(9):987-995. PubMed ID: 26237428
[TBL] [Abstract][Full Text] [Related]
6. TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.
Bonvin E; Radaelli E; Bizet M; Luciani F; Calonne E; Putmans P; Nittner D; Singh NK; Santagostino SF; Petit V; Larue L; Marine JC; Fuks F
Cancer Res; 2019 Feb; 79(3):482-494. PubMed ID: 30538121
[TBL] [Abstract][Full Text] [Related]
7. Variants at the 9p21 locus and melanoma risk.
Maccioni L; Rachakonda PS; Bermejo JL; Planelles D; Requena C; Hemminki K; Nagore E; Kumar R
BMC Cancer; 2013 Jul; 13():325. PubMed ID: 23816148
[TBL] [Abstract][Full Text] [Related]
8. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.
Amos CI; Wang LE; Lee JE; Gershenwald JE; Chen WV; Fang S; Kosoy R; Zhang M; Qureshi AA; Vattathil S; Schacherer CW; Gardner JM; Wang Y; Bishop DT; Barrett JH; ; MacGregor S; Hayward NK; Martin NG; Duffy DL; ; Mann GJ; Cust A; Hopper J; ; Brown KM; Grimm EA; Xu Y; Han Y; Jing K; McHugh C; Laurie CC; Doheny KF; Pugh EW; Seldin MF; Han J; Wei Q
Hum Mol Genet; 2011 Dec; 20(24):5012-23. PubMed ID: 21926416
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in telomere-maintaining genes and skin cancer risk.
Nan H; Qureshi AA; Prescott J; De Vivo I; Han J
Hum Genet; 2011 Mar; 129(3):247-53. PubMed ID: 21116649
[TBL] [Abstract][Full Text] [Related]
11. Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.
Ransohoff KJ; Wu W; Cho HG; Chahal HC; Lin Y; Dai HJ; Amos CI; Lee JE; Tang JY; Hinds DA; Han J; Wei Q; Sarin KY
Oncotarget; 2017 Mar; 8(11):17586-17592. PubMed ID: 28212542
[TBL] [Abstract][Full Text] [Related]
12. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
13. Common sequence variants on 20q11.22 confer melanoma susceptibility.
Brown KM; Macgregor S; Montgomery GW; Craig DW; Zhao ZZ; Iyadurai K; Henders AK; Homer N; Campbell MJ; Stark M; Thomas S; Schmid H; Holland EA; Gillanders EM; Duffy DL; Maskiell JA; Jetann J; Ferguson M; Stephan DA; Cust AE; Whiteman D; Green A; Olsson H; Puig S; Ghiorzo P; Hansson J; Demenais F; Goldstein AM; Gruis NA; Elder DE; Bishop JN; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Martin NG; Trent JM; Mann GJ; Hayward NK
Nat Genet; 2008 Jul; 40(7):838-40. PubMed ID: 18488026
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
15. No association between Parkinson disease alleles and the risk of melanoma.
Meng S; Song F; Chen H; Gao X; Amos CI; Lee JE; Wei Q; Qureshi AA; Han J
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):243-5. PubMed ID: 22086882
[TBL] [Abstract][Full Text] [Related]
16. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
17. Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.
Liu H; Wang LE; Liu Z; Chen WV; Amos CI; Lee JE; ; ; Iles MM; Law MH; Barrett JH; Montgomery GW; Taylor JC; MacGregor S; Cust AE; Newton Bishop JA; Hayward NK; Bishop DT; Mann GJ; Affleck P; Wei Q
Carcinogenesis; 2013 Apr; 34(4):885-92. PubMed ID: 23291271
[TBL] [Abstract][Full Text] [Related]
18. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
19. Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.
Li R; Xu MJ; Yang FC; Zhou Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):583-588. PubMed ID: 27825418
[TBL] [Abstract][Full Text] [Related]
20. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
